Moleculera
1 known investors
Find your way into Moleculera
Sign up to see every warm intro you have to Moleculera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Moleculera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.
Investors · 1
Frequently asked questions
- What does Moleculera do?
- Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.
- Who are Moleculera's investors?
- Moleculera's investors include Prolog Ventures.

